SPY759.65+1.30%QQQ690.23+2.29%BTC/USD74,587.26+1.21%DIA524.24+0.48%GLD365.25−1.11%TLT80.91+0.04%

Nephros Inc

NEPHNASDAQ

Trade with Public

Price data is not available

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Earnings: Q3 2026 Earnings were released on Thu Nov 5th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 6 days ago

Click to view the webcast

Nephros (NEPH) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Nephros (NEPH) stock.

Analyst Consensus — 1 Analysts

1Buy

# Analysts1

Latest Upgrades and Downgrades for Nephros Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Maxim Group	Anthony Vendetti	PT Raise	Buy	$5→$6
—	Benchmark	Robert Wasserman	Maintained	Speculative Buy	$5
—	Benchmark	Robert Wasserman	Maintained	Speculative Buy	$5
—	Benchmark	Robert Wasserman	Upgrade	Hold→Speculative Buy	$5

Nephros Inc

Nephros (NEPH) Stock Price Target 2026

Latest Upgrades and Downgrades for Nephros Stock

Nephros (NEPH) Stock Price Target 2026

Latest Upgrades and Downgrades for Nephros Stock

Analyst Ratings News

PRO
Maxim Group Maintains Buy on Nephros, Raises Price Target to $6

PRO
Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PRO
Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PRO
Benchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target

Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2021

PRO
B. Riley FBR Initiates Coverage On Nephros with Buy Rating, Announces Price Target of $12.5

People Also Watch

Analyst Ratings News

PRO
Maxim Group Maintains Buy on Nephros, Raises Price Target to $6

PRO
Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PRO
Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PRO
Benchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target

Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2021

PRO
B. Riley FBR Initiates Coverage On Nephros with Buy Rating, Announces Price Target of $12.5

People Also Watch

Nephros Inc

Nephros (NEPH) Stock Price Target 2026

Latest Upgrades and Downgrades for Nephros Stock

Nephros (NEPH) Stock Price Target 2026

Latest Upgrades and Downgrades for Nephros Stock

Analyst Ratings News

PROMaxim Group Maintains Buy on Nephros, Raises Price Target to $6

PROBenchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PROBenchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PROBenchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target

Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2021

PROB. Riley FBR Initiates Coverage On Nephros with Buy Rating, Announces Price Target of $12.5

People Also Watch

Analyst Ratings News

PROMaxim Group Maintains Buy on Nephros, Raises Price Target to $6

PROBenchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PROBenchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PROBenchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target

Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2021

PROB. Riley FBR Initiates Coverage On Nephros with Buy Rating, Announces Price Target of $12.5

People Also Watch

PRO
Maxim Group Maintains Buy on Nephros, Raises Price Target to $6

PRO
Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PRO
Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PRO
Benchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target

PRO
B. Riley FBR Initiates Coverage On Nephros with Buy Rating, Announces Price Target of $12.5

PRO
Maxim Group Maintains Buy on Nephros, Raises Price Target to $6

PRO
Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PRO
Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

PRO
Benchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target

PRO
B. Riley FBR Initiates Coverage On Nephros with Buy Rating, Announces Price Target of $12.5